A
ISSUER//CIK 0001096481
ANGIOTECH PHARMACEUTICALS INC
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Recent Filings
- 10-K38.6 MBANGIOTECH PHARMACEUTICALS INCMar 28, 5:30 PM ET·0001104659-13-025472
- 8-K425.9 KBANGIOTECH PHARMACEUTICALS INCMar 28, 5:28 PM ET·0001104659-13-025470
- 8-K60.0 KBANGIOTECH PHARMACEUTICALS INCMar 26, 5:02 PM ET·0001104659-13-024490
- 8-K61.5 KBANGIOTECH PHARMACEUTICALS INCMar 19, 11:41 AM ET·0001104659-13-022037
- 8-K23.4 KBANGIOTECH PHARMACEUTICALS INCNov 14, 9:41 PM ET·0001104659-12-077968
- 8-K425.0 KBANGIOTECH PHARMACEUTICALS INCNov 14, 4:56 PM ET·0001104659-12-077958
- 10-Q28.9 MBANGIOTECH PHARMACEUTICALS INCNov 14, 4:53 PM ET·0001104659-12-077956
- 10-Q/A1.1 MBANGIOTECH PHARMACEUTICALS INCNov 13, 12:33 PM ET·0001104659-12-077212
- 8-K47.9 KBANGIOTECH PHARMACEUTICALS INCSep 20, 4:33 PM ET·0001193125-12-398457
- 10-Q/A26.8 MBANGIOTECH PHARMACEUTICALS INCSep 13, 4:58 PM ET·0001104659-12-063321
Insiders
10- Avelar RuiChief Medical Officer
- Bailey K ThomasChief Financial Officer
- Brege LauraDirector
- Brown Edward MDirector
- Bryant Steven R.SVP, Specialty Medical Device
- Cunliffe SeanSVP, Sales & Marketing
- Dennis Christopher John WesleyVP, Commercial Operations
- Dent Jay BernardSVP, Finance
- Diaz Victor ManuelSr VP, Global Manufacturing
- Gross Jeffrey MSVP, Research & Development
Tickers
No tickers on record
Addresses
business
1618 STATION STREET
VANCOUVER, A1, V6A 1B6
mailing
1618 STATION STREET
VANCOUVER, A1, V6A 1B6